Source: ALL
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cadherin 2 | 0.535 | 0.731 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2009 | 2009 | ||||||||
|
organic cation transporter 3 | 0.805 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 708 | 0.570 | 0.692 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MHC class I polypeptide-related sequence C (pseudogene) | 0.890 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
high mobility group AT-hook 1 pseudogene 8 | 1.000 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
interstitial pneumonitis, desquamative, familial | 0.678 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
WASH complex subunit 1 | 0.780 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 994 | 0.839 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
GNG12, DIRAS3 and WLS antisense RNA 1 | 0.861 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
defensin beta 4B | 0.510 | 0.769 | 6.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
complement component 4B (Chido blood group), copy 2 | 0.670 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | |||||||||
|
Polymicrogyria, bilateral occipital | 0.722 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 1910 | 0.931 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
Leukemia, acute lymphoblastic, susceptibility to, 2 | 0.861 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 3188 | 0.769 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||
|
microRNA 3939 | 1.000 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
microRNA 3666 | 0.700 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
VIM antisense RNA 1 | 0.780 | 0.385 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
LY75-CD302 readthrough | 0.711 | 0.423 | 7.4E-46 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
RBM14-RBM4 readthrough | 0.647 | 0.615 | 0.98 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
RPS10-NUDT3 readthrough | 0.931 | 0.154 | 0.95 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
COMMD3-BMI1 readthrough | 0.488 | 0.769 | 1.5E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
microRNA 4756 | 0.861 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |